U.S. Markets open in 3 hrs 3 mins

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1900+0.0900 (+2.90%)
At close: 4:00PM EDT
3.2600 +0.07 (2.19%)
Pre-Market: 06:27AM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.93
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.0200
52 Week Low 31.7100
50-Day Moving Average 32.9671
200-Day Moving Average 33.5699

Share Statistics

Avg Vol (3 month) 31.3M
Avg Vol (10 day) 31.24M
Shares Outstanding 596.34M
Implied Shares Outstanding 6N/A
Float 70.01M
% Held by Insiders 118.71%
% Held by Institutions 125.33%
Shares Short (Apr 14, 2021) 44.22M
Short Ratio (Apr 14, 2021) 43.22
Short % of Float (Apr 14, 2021) 45.46%
Short % of Shares Outstanding (Apr 14, 2021) 44.33%
Shares Short (prior month Mar 14, 2021) 43.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov 03, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-828.30%

Management Effectiveness

Return on Assets (ttm)-29.51%
Return on Equity (ttm)-72.97%

Income Statement

Revenue (ttm)6.91M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)47.50%
Gross Profit (ttm)-40.57M
EBITDA -55.29M
Net Income Avi to Common (ttm)-75.87M
Diluted EPS (ttm)-1.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)123.27M
Total Cash Per Share (mrq)1.29
Total Debt (mrq)2.98M
Total Debt/Equity (mrq)2.92
Current Ratio (mrq)13.39
Book Value Per Share (mrq)-0.53

Cash Flow Statement

Operating Cash Flow (ttm)-51.44M
Levered Free Cash Flow (ttm)-30.17M